Is Trending Stock Vertex Pharmaceuticals Incorporated (VRTX) a Buy Now?

Vertex Pharmaceuticals (VRTX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over the past month, shares of this drugmaker have returned -3.6%, compared to the Zacks S&P 500 composite's +2% change. During this period, the Zacks Medical - Biomedical and Genetics industry, which Vertex falls in, has lost 1.5%. The key question now is: What could be the stock's future direction? ...